
LY2922470
CAS No. 1423018-12-5
LY2922470( LY-2922470 | LY 2922470 )
Catalog No. M11781 CAS No. 1423018-12-5
LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM; displays no activity against PPARα/β/γ (>10 uM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 224 | Get Quote |
![]() ![]() |
10MG | 337 | Get Quote |
![]() ![]() |
25MG | 584 | Get Quote |
![]() ![]() |
50MG | 833 | Get Quote |
![]() ![]() |
100MG | 1134 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLY2922470
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM; displays no activity against PPARα/β/γ (>10 uM).
-
DescriptionLY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM; displays no activity against PPARα/β/γ (>10 uM); demonstrates potent, efficacious, and durable dose-dependent reductions in glucose levels along with significant increases in insulin and GLP-1 secretion in vivo.Diabetes Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsLY-2922470 | LY 2922470
-
PathwayGPCR/G Protein
-
TargetFFAR
-
RecptorFFAR
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number1423018-12-5
-
Formula Weight475.603
-
Molecular FormulaC28H29NO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 125 mg/mL 262.83 mM
-
SMILESO=C(C[C@@H](C1=CC=C(OCC2=CC=C(CN3CCCC4=C3C(OC)=CC=C4)S2)C=C1)C#CC)O
-
Chemical Name(S)-3-(4-((5-((8-methoxy-3,4-dihydroquinolin-1(2H)-yl)methyl)thiophen-2-yl)methoxy)phenyl)hex-4-ynoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hamdouchi C, et al. J Med Chem. 2016 Dec 22;59(24):10891-10916.
molnova catalog



related products
-
PBI-4050 sodium
PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively.
-
Fasiglifam
A potent, selective, orally bioavailable GPR40 (FFA1) agonist with EC50 of 14 nM.
-
GLPG 0974
GLPG 0974 is a potent, selective free fatty acid receptor 2 (FFA2, GPR43) antagonist with IC50 of 95 nM.